APG Asset Management N.V. Sells 29,600 Shares of Colgate-Palmolive Company $CL

APG Asset Management N.V. decreased its position in Colgate-Palmolive Company (NYSE:CL) by 2.4% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,207,622 shares of the company’s stock after selling 29,600 shares during the period. APG Asset Management N.V. owned about 0.15% of Colgate-Palmolive worth $96,537,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Westside Investment Management Inc. grew its position in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares in the last quarter. Copia Wealth Management bought a new position in shares of Colgate-Palmolive in the 3rd quarter valued at about $29,000. Vermillion & White Wealth Management Group LLC increased its position in shares of Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after acquiring an additional 155 shares during the last quarter. Cloud Capital Management LLC acquired a new position in Colgate-Palmolive during the third quarter valued at approximately $30,000. Finally, MTM Investment Management LLC bought a new position in Colgate-Palmolive in the second quarter valued at approximately $39,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CL has been the topic of a number of analyst reports. UBS Group upped their price objective on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a research report on Friday, February 13th. Barclays increased their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Bank of America boosted their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Finally, JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Stock Up 1.5%

Shares of CL opened at $99.01 on Friday. The firm has a market cap of $79.81 billion, a P/E ratio of 37.79, a price-to-earnings-growth ratio of 4.47 and a beta of 0.29. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.27 and a current ratio of 0.83. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The firm’s 50-day simple moving average is $87.49 and its 200 day simple moving average is $82.72.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 earnings per share. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. This represents a 63.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 over the last ninety days. Corporate insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.